LOS ANGELES, Oct. 23, 2017 -- PacWest Bancorp (NASDAQ:PACW) (“PacWest”) today announced the completion of its merger with CU Bancorp (NASDAQ:CUNB) (“CUB”), effective on October 20, 2017. In conjunction with this merger, California United Bank, a wholly-owned subsidiary of CUB, was merged with and into PacWest’s banking subsidiary, Pacific Western Bank.
Matt Wagner, CEO of PacWest and Pacific Western Bank, stated, “We believe the CUB acquisition significantly enhances our Southern California community bank franchise with the addition of $2.7 billion of core deposits, a high-quality loan portfolio totaling $2.1 billion and a team of very experienced bankers.”
Under the terms of the Agreement and Plan of Merger, each CUB common share, except dissenting shares, and each restricted stock award was converted into the right to receive 0.5308 of a share of PacWest common stock and $12.00 in cash, and each outstanding CUB stock option will be settled in cash pursuant to terms of the Agreement and Plan of Merger. PacWest is issuing an aggregate of approximately 9.3 million shares of PacWest common stock and paying approximately $224 million in cash to CUB common shareholders and equity award holders. Based on the closing price of PacWest’s common stock on October 20, 2017 of $47.99 per share, the aggregate consideration payable to CUB common shareholders and equity awards holders is approximately $681 million.
ABOUT PACWEST
PacWest Bancorp (“PacWest”) is a bank holding company with over $25 billion in assets with one wholly-owned banking subsidiary, Pacific Western Bank (“Pacific Western”). Pacific Western has 83 full-service branches located throughout the state of California and one branch in Durham, North Carolina. Pacific Western provides commercial banking services, including real estate, construction, and commercial loans, and comprehensive deposit and treasury management services to small and medium-sized businesses. Pacific Western offers additional products and services under the brands of its business divisions, CapitalSource and Square 1 Bank. The CapitalSource Division provides cash flow, asset-based, equipment and real estate loans, as well as treasury management services to middle market businesses on a national basis. The Square 1 Bank Division offers a comprehensive suite of financial services focused on entrepreneurial businesses and their venture capital and private equity investors, with offices located in all key innovative hubs across the United States. For more information about PacWest, visit www.pacwestbancorp.com, or to learn more about Pacific Western Bank, visit www.pacificwesternbank.com.
Contacts:
Matthew P. Wagner
Chief Executive Officer
(310) 887-8520
Don Destino
Executive Vice President,
Corporate Development and Investor Relations
(310) 887-8521


Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Grok AI Faces Global Scrutiny Over Safeguard Failures and Illegal Content on X
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 



